Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
16 hedge funds and large institutions have $834K invested in Vaccinex, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
33% more funds holding
Funds holding: 12 → 16 (+4)
80% less capital invested
Capital invested by funds: $4.26M → $834K (-$3.42M)
88% less call options, than puts
Call options by funds: $22K | Put options by funds: $187K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TI
Telemetry Investments
New York
|
+$303K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$239K |
| 3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$237K |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$161K |
| 5 |
VF
Virtu Financial
New York
|
+$136K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MP
MSD Partners
New York
|
-$3.33M |
| 2 |
Millennium Management
New York
|
-$111K |
| 3 |
OC
Oppenheimer & Co
New York
|
-$61.1K |
| 4 |
Bank of New York Mellon
New York
|
-$57K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
VCNX Hedge Fund Activity: Q3 2020 in Review
16 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q3 2020, worth a combined $834K — down 80% from $4.26M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new VCNX positions and 5 closed out — a net gain of 4 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Telemetry Investments, opening a new position worth an estimated $303K. The largest seller was MSD Partners, exiting entirely with an estimated $3.33M sold.
- 16 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q3 2020, up from 12 in Q2 2020.
- Funds reported $834K of Vaccinex, Inc. Common Stock stock for Q3 2020, down 80% quarter-over-quarter.
- 9 funds opened new Vaccinex, Inc. Common Stock positions in Q3 2020 and 5 closed out, a net change of +4 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q3 2020 was Telemetry Investments, an estimated $303K added.
- The largest Vaccinex, Inc. Common Stock seller in Q3 2020 was MSD Partners, an estimated $3.33M sold.
Based on aggregated 13F filings for Q3 2020.